Thursday, December 30, 2021

Exton-based Castle Creek Biosciences withdraws plans for $100M IPO - The Business Journals

The company's lead gene therapy candidate, D-Fi, is in late-stage clinical testing as a potential treatment of recessive dystrophic epidermolysis ...

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

2 muggers captured by RU students on campus - UNB

Rayhanul Ferdous, a student of Genetic Engineering and Biotechnology department who had his phone stolen told UNB: “I was walking on the eas...